Your browser doesn't support javascript.
loading
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Böll, Boris; Schalk, Enrico; Buchheidt, Dieter; Hasenkamp, Justin; Kiehl, Michael; Kiderlen, Til Ramon; Kochanek, Matthias; Koldehoff, Michael; Kostrewa, Philippe; Claßen, Annika Y; Mellinghoff, Sibylle C; Metzner, Bernd; Penack, Olaf; Ruhnke, Markus; Vehreschild, Maria J G T; Weissinger, Florian; Wolf, Hans-Heinrich; Karthaus, Meinolf; Hentrich, Marcus.
Afiliación
  • Böll B; Department I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. boris.boell@uk-koeln.de.
  • Schalk E; Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Medical Center, Magdeburg, Germany.
  • Buchheidt D; Department of Hematology and Oncology, Mannheim University Hospital, Heidelberg University, Mannheim, Germany.
  • Hasenkamp J; Clinic for Hematology and Oncology, University Medicine Göttingen, Georg-August-University, Göttingen, Germany.
  • Kiehl M; Department of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt/Oder, Germany.
  • Kiderlen TR; Department of Hematology, Oncology and Palliative Care, Vivantes Clinic Neukoelln, Berlin, Germany.
  • Kochanek M; Department I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
  • Koldehoff M; Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Kostrewa P; Department of Hematology and Oncology, Campus Fulda, Philipps-University Marburg, Fulda, Germany.
  • Claßen AY; Department I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
  • Mellinghoff SC; Department I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
  • Metzner B; Department of Hematology and Oncology, University Hospital Oldenburg, Oldenburg, Germany.
  • Penack O; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ruhnke M; Department of Hematology and Oncology, Helios Klinikum Aue, Aue, Germany.
  • Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Weissinger F; Department of Hematology, Oncology and Palliative Care, Department of Internal Medicine, Evangelisches Klinikum Bethel, Bielefeld, Germany.
  • Wolf HH; Department III of Internal Medicine, Hematology, Oncology and Hemostaseology, Südharzklinikum, Nordhausen, Germany.
  • Karthaus M; Department of Hematology, Oncology & Palliative Care, Klinikum Neuperlach, Munich, Germany.
  • Hentrich M; Department of Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany.
Ann Hematol ; 100(1): 239-259, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32997191
ABSTRACT
Cancer patients frequently require central venous catheters for therapy and parenteral nutrition and are at high risk of central venous catheter-related infections (CRIs). Moreover, CRIs prolong hospitalization, cause an excess in resource utilization and treatment cost, often delay anti-cancer treatment, and are associated with a significant increase in mortality in cancer patients. We therefore summoned a panel of experts by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) and updated our previous guideline on CRIs in cancer patients. After conducting systematic literature searches on PubMed, Medline, and Cochrane databases, video- and meeting-based consensus discussions were held. In the presented guideline, we summarize recommendations on definition, diagnosis, management, and prevention of CRIs in cancer patients including the grading of strength of recommendations and the respective levels of evidence. This guideline supports clinicians and researchers alike in the evidence-based decision-making in the management of CRIs in cancer patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Guías de Práctica Clínica como Asunto / Infecciones Relacionadas con Catéteres / Hematología / Oncología Médica Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Systematic_reviews Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sociedades Médicas / Guías de Práctica Clínica como Asunto / Infecciones Relacionadas con Catéteres / Hematología / Oncología Médica Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Systematic_reviews Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania